O.O. Melnyk

Phase II Study of Efficacy and Safety of Bevacizumab in Combination With Chemotherapy or Erlotinib Compared With Chemotherapy Alone for Treatment of Recurrent or Refractory Non–Small-Cell Lung Cancer

Roy S. Herbst, Vincent O’Neill, Louis Fehrenbacher et al. · Journal of Clinical Oncology · 2007 · 396 citations · Full text

Medicine, Oncology, Pharmacology +13

Characterization of a candidate bcl-1 gene.

D A Withers, Richard C. Harvey, John B. Faust et al. · Molecular and Cellular Biology · 1991 · 344 citations · Full text

Life Sciences, Genetics, Molecular Biology +13

Magnetic Resonance Imaging Detects Suppression of Tumor Vascular Permeability After Administration of Antibody to Vascular Endothelial Growth Factor

Christine D. Pham, Timothy P. L. Roberts, Nick van Bruggen et al. · Cancer Investigation · 1998 · 208 citations

Medicine, Cancer Biology, Oncology +17

NEUTRALIZING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIBODY INHIBITS FURTHER GROWTH OF ESTABLISHED PROSTATE CANCER AND METASTASES IN A PRE-CLINICAL MODEL

O.O. Melnyk, M B Zimmerman, K. JIN KIM et al. · The Journal of Urology · 1999 · 160 citations

Medicine, Oncology, Pharmacology +17

Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth.

O.O. Melnyk, Marc A. Shuman, K J Kim · PubMed · 1996 · 133 citations

Medicine, Cancer Biology, Oncology +13